10% Off
Ologen0.1%
Olopatadine Hydrochloride
General Pharmaceuticals Ltd.
৳99.00
Add to cart
Contova0.1%
Ophthalmic Solution
Olopatadine Hydrochloride
ACI Limited
Product Code : 4062
10% Off
Best PriceTk
/
1
Alternatives
See All
10% Off
Opatin0.1%
Olopatadine Hydrochloride
Opsonin Pharma Ltd.
৳99.00
Add to cart
10% Off
Lopadine0.1%
Olopatadine Hydrochloride
Incepta Pharmaceuticals Ltd.
৳99.00
Add to cart
10% Off
Patalon0.1%
Olopatadine Hydrochloride
Ibn-Sina Pharmaceuticals Ltd.
৳99.00
Add to cart
10% Off
Alacot0.1%
Olopatadine Hydrochloride
Square Pharmaceuticals Ltd.
৳99.31
Add to cart
10% Off
Olopan0.1%
Olopatadine Hydrochloride
Beximco Pharmaceuticals Ltd.
৳99.00
Add to cart
10% Off
Aladay0.1%
Olopatadine Hydrochloride
Eskayef Bangladesh Ltd.
৳99.00
Add to cart
10% Off
Alercon0.1%
Olopatadine Hydrochloride
ACME Laboratories Ltd.
৳90.27
Add to cart
10% Off
Alleloc0.1%
Olopatadine Hydrochloride
Navana Pharmaceuticals Ltd.
৳90.27
Out Of Stock
10% Off
Allet0.1%
Olopatadine Hydrochloride
Healthcare Pharmacuticals Ltd.
৳99.00
Out Of Stock
10% Off
Conrif0.1%
Olopatadine Hydrochloride
Globe Pharmaceuticals Ltd.
৳90.00
Add to cart
10% Off
Olarif0.1%
Olopatadine Hydrochloride
Biopharma Laboratories Ltd.
৳99.00
Out Of Stock
10% Off
Olofix0.1%
Olopatadine Hydrochloride
Opso Saline Ltd.
৳99.02
Out Of Stock
10% Off
Patadin0.1%
Olopatadine Hydrochloride
Popular Pharmaceuticals Ltd.
৳90.34
Add to cart
Medicine overview
Indications of Contova 0.1%
Olopatadine is indicated for the treatment of ocular itching associated with allergic conjunctivitis.
Theropeutic Class
Ophthalmic Non-Steroid drugs
Pharmacology
Olopatadine is an inhibitor of the release of histamine from the mast cell and a relatively selective histamine H1‐antagonist that inhibits the in vivo and in vitro type 1 immediate hypersensitivity reaction including inhibition of histamine induced effects on human conjunctival epithelial cells. Olopatadine is devoid of effects on alpha adrenergic, dopamine and muscarinic type 1 and 2 receptors. Following topical ocular administration in human, olopatadine was shown to have low systemic exposure.
Dosage & Administration of Contova 0.1%
0.1% Sterile Eye Drops: One drop in each affected eye two times per day at an interval of 6 to 8 hours. 0.2% Sterile Eye Drops: One drop in the affected eye once a day.0.7% Sterile Eye Drops: One drop in each affected eye once a day.
Interaction of Contova 0.1%
May result in additive CNS depression with CNS depressants.
Contraindications
Contova 0.1% ophthalmic solution is contraindicated in persons with a known hypersensitivity to Contova 0.1%.
Side Effects of Contova 0.1%
Headaches have been reported at an incidence of 7%. The following adverse experiences have been reported in less than 5% of patients: Asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, and taste perversion
Pregnancy & Lactation
There are no adequate and well controlled studies in pregnant women. Because animal studies are not always predictive of human responses, this drug should be used in pregnant women only if the potential benefit to the mother justifies the potential risk to the fetus.It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in the human breast milk. Nevertheless, caution should be exercised when Contova 0.1% ophthalmic solution is administered to a nursing mother.
Precautions & Warnings
Olopatadine HCl ophthalmic solution should not be used to treat contact lens related irritation. Patients who wear soft contact lenses should be instructed to wait at least ten minutes after instilling Contova 0.1% ophthalmic solution before they insert their contact lenses.
Overdose Effects of Contova 0.1%
Symptoms: Drowsiness in adults and, initially, agitation and restlessness, followed by drowsiness in childn. Management: Symptomatic or supportive treatment.
Storage Conditions
Store below 30° C in a cool and dry place protected from light. Keep out of reach of children. Do not touch the dropper tip to surfaces since this may contaminate the solution. Do not use after 30 days of first opening.
Use In Special Populations
Geriatric Use: No overall differences in safety or effectiveness have been observed betweents.
Disclaimer
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.
